NLRP3 and CINCA syndrome: Approximately 100 pathogenic NLRP3 mutations have been reported in NLRP3-AID patients with solid genotype–phenotype correlation along the disease continuum from mild type (FCAS), moderate type (MWS) to severe type (CINCA) (8).